TY - CONF T1 - Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Patients Co-infected with HCV and HIV-1: The Phase 3 ASTRAL-5 Study Abstract PS104 T2 - International Liver Congress 2016. April 13-17. Y1 - 2016 A1 - D L Wyles A1 - Brau, N. A1 - Kottilil, S. A1 - et, al AB -

PS104

JA - International Liver Congress 2016. April 13-17. CY - Barcelona, Spain ER -